BradsaudeBSP:SAUD3 +2.00%94 EBITDA Margin % is 40.36% as of Mar. 2026, which is 30% above its 10-year median of 31.02. GuruFocus rates BSP:SAUD3 with a GF Score™ of 94/100 and a GF Value™ of R$13.48 (Fairly Valued). The stock has 6 warning signs investors should review. Among 18 Healthcare Plans companies, Bradsaude ranks better than 94.44% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bradsaude's EBITDA for the
three
months ended in Mar. 2026 was R$248 Mil. Bradsaude's Revenue for the
three
months ended in Mar. 2026 was R$615 Mil. Therefore, Bradsaude's EBITDA margin for the quarter that ended in Mar. 2026 was 40.36%.
Bradsaude (BSP:SAUD3) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bradsaude EBITDA Margin % Related Terms
Bradsaude EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Bradsaude's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:SAUD3 vs UNH, CVS, ELV: EBITDA Margin % Comparison
For the Healthcare Plans subindustry, Bradsaude's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bradsaude EBITDA Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Bradsaude's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bradsaude's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bradsaude (BSP:SAUD3) has a EBITDA Margin % of 40.36% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bradsaude and its competitors. This is 30% above median its historical median of 31.02. Over the past decade, Bradsaude's EBITDA Margin % has ranged from 21.09 to 48.86. According to the industry distribution chart, Bradsaude ranks #1 out of 18 companies in the Healthcare Plans industry, placing it in the top 5.6%.
Is Bradsaude's EBITDA Margin % too high?
Bradsaude's current EBITDA Margin % of 40.36% is 30% above median its 10-year median of 31.02. Over the past 10 years, this metric has ranged from a low of 21.09 to a high of 48.86. The Healthcare Plans industry median EBITDA Margin % is 4.56. Bradsaude's value of 40.36% is 786.1% above this industry median. Based on the distribution chart, Bradsaude ranks #1 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Bradsaude has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bradsaude's EBITDA Margin % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Bradsaude ranks #1 out of 18 companies for EBITDA Margin %. This places Bradsaude in the top 6% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.56. Bradsaude's value of 40.36% is 786.1% above this benchmark. Historically, Bradsaude's own EBITDA Margin % has ranged from 21.09 to 48.86 over the past decade. While the company's 10-year median is 31.02 vs. the industry median of 4.56, Bradsaude has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Plans company?
The median EBITDA Margin % among Healthcare Plans companies is 4.56, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bradsaude's current EBITDA Margin % of 40.36% is 786.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bradsaude and its competitors. For the Healthcare Plans industry, the median EBITDA Margin % is 4.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bradsaude's current EBITDA Margin % is 40.36%, which is 30% above median its own 10-year median of 31.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bradsaude stock overvalued right now?
Based on GuruFocus' analysis, Bradsaude (BSP:SAUD3) is currently considered Fairly Valued. The stock's GF Value™ is R$13.48, compared to a current price of R$14.28 — trading 5.9% above its estimated fair value. The current EBITDA Margin % is 40.36%, which is 30% above median its 10-year median of 31.02 and 786.1% above the Healthcare Plans industry median of 4.56. Bradsaude's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bradsaude (BSP:SAUD3), the current EBITDA Margin % is 40.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bradsaude (BSP:SAUD3) Overvalued in 2026?
Based on GuruFocus' analysis, Bradsaude stock appears to be overvalued.
The current stock price of R$14.28 is trading 5.9% above its estimated GF Value™ of R$13.48.
GuruFocus considers Bradsaude to be Fairly Valued.
Key valuation signals for BSP:SAUD3:
EBITDA Margin %: 40.36% (30% above median its 10-year median of 31.02)
GF Value™: R$13.48 vs. price of R$14.28 (5.9% above fair value)
Industry Position: 786.1% above the Healthcare Plans median (#1 of 18)
No single metric tells the full story. See the BSP:SAUD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bradsaude SA operates a healthcare ecosystem in Brazil formed through the consolidation of companies across different healthcare segments. Its operations include health and dental insurance, hospitals, primary care clinics, healthcare technology, diagnostics, and oncology services. The company serves more than 13 million beneficiaries and operates a healthcare network that includes approximately 4,000 hospital beds across the country.
94GF Score
Get the complete analysis for BSP:SAUD3
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:SAUD3 has been successfully added to your 
